Hydroflumethiazide

Hydroflumethiazide
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gerald Chi

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Hydroflumethiazide is a thiazide-like diuretic that is FDA approved for the {{{indicationType}}} of hypertension and edema associated with congestive heart failure, hepatic cirrhosis, corticosteroid and estrogen therapy, and renal dysfunction. Common adverse reactions include hyponatremia, hypokalemia, hyperglycemia, orthostatic hypotension, photosensitivity, loss of appetite, nausea, vomiting, and diarrhea.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

• Therapy should be individualized according to patient response. This therapy should be titrated to gain maximal therapeutic response, as well as the minimal dose possible to maintain that therapeutic response.

Edema

• Dosing Information

• Initial Dosage

• 50 to 200 mg daily, in 1 or 2 divided doses

• Maintenance Dosage

• 25 to 50 mg on alternate days or intermittently

Hypertension

• Dosing Information

• 25 to 50 mg daily in 1 or 2 divided doses, either alone, or in conjunction with other antihypertensive agents

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hydroflumethiazide in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroflumethiazide in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Edema

• Dosing Information

• A suggested initial dose for children is 1 mg/kg of body weight daily, reduced for maintenance.

Hypertension

• Dosing Information

• A suggested initial dose for children is 1 mg/kg of body weight daily, reduced for maintenance.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Hydroflumethiazide in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroflumethiazide in pediatric patients.

Contraindications

• Hypersensitivity to this or other sulfonamide-derived drugs

Warnings

• Description

Precautions

• Description

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Hydroflumethiazide in the drug label.

Central Nervous System

Cardiovascular

Respiratory

Gastrointestinal

Hypersensitivity

Miscellaneous

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Hydroflumethiazide in the drug label.

Central Nervous System

Cardiovascular

Respiratory

Gastrointestinal

Hypersensitivity

Miscellaneous

Drug Interactions

• Drug

• Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

• Pregnancy Category

Pregnancy Category (AUS):

• Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hydroflumethiazide in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Hydroflumethiazide during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Hydroflumethiazide with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Hydroflumethiazide with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Hydroflumethiazide with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Hydroflumethiazide with respect to specific gender populations.

Race

There is no FDA guidance on the use of Hydroflumethiazide with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Hydroflumethiazide in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Hydroflumethiazide in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Hydroflumethiazide in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Hydroflumethiazide in patients who are immunocompromised.

Administration and Monitoring

Administration

• Oral

• Intravenous

Monitoring

There is limited information regarding Monitoring of Hydroflumethiazide in the drug label.

Condition1

• Description

IV Compatibility

There is limited information regarding IV Compatibility of Hydroflumethiazide in the drug label.

Overdosage

Acute Overdose

Signs and Symptoms

• Description

Management

• Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Hydroflumethiazide in the drug label.

Pharmacology

Mechanism of Action

Structure

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Hydroflumethiazide in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Hydroflumethiazide in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Hydroflumethiazide in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Hydroflumethiazide in the drug label.

Condition1

• Description

How Supplied

Storage

There is limited information regarding Hydroflumethiazide Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Hydroflumethiazide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Hydroflumethiazide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Hydroflumethiazide in the drug label.

Precautions with Alcohol

• Alcohol-Hydroflumethiazide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

• Saluron®

Look-Alike Drug Names

• N/A

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

{{#subobject:

 |Page Name=Hydroflumethiazide
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage=
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Hydroflumethiazide
 |Label Name=Hydroflumethiazide11.png

}}

{{#subobject:

 |Label Page=Hydroflumethiazide
 |Label Name=Hydroflumethiazide11.png

}}